1st Quarter - Report

GENENTECH, INC for GENENTECH INC

Firm
Client
Income
—
Expenses
$1,160,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade Policy Issues. Trade Negotiations.

LobbyistCovered position, as disclosed
DAVID B BURT —
CATHERINE LYTTON PHILLIPS —
ANDREW WESLEY WOMACK —

Contacted: Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); White House Office; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Medical/Disease Research/Clinical Labs MED

Issues related to Right to Try

LobbyistCovered position, as disclosed
DAVID B BURT —
ANDREW WESLEY WOMACK —

Contacted: White House Office; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); SENATE

Taxation/Internal Revenue Code TAX

H.R.1, Tax Reform Act of 2017 (Public Law No. 115-97) Issues related to the tax reform bill and implementation

LobbyistCovered position, as disclosed
DAVID B BURT —
CATHERINE LYTTON PHILLIPS —
MATTHEW L SULKALA —

Contacted: White House Office; SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (115th)

Health Issues HCR

H.R. 4710 - 340B Protecting Access for the Underserved and Safety-Net Entities Act. S. 2312 - The Helping Ensure Low-income Patients have Access to Care and Treatment Act S. 2453 - Ensuring the Value of the 340B Program Act of 2018 S.204/H.R.878, Trickett Wendler Right to Try Act of 2017. P.L.109-417, Pandemic and All-Hazards Preparedness Act (PAHPA). Policies relating to the 340B Drug Discount Program Development of Policies to advance antimicrobial research and novel product development environment, including advancing new market incentives. Issues and policies relating to the Food and Drug Administration including biopharmaceutical development, drug safety and counterfeiting, and biosimilars. General education about policies impacting pharmaceutical development, approval, reimbursement and pricing.

LobbyistCovered position, as disclosed
DAVID B BURT —
ELISE MARIE CONNER —
CATHERINE LYTTON PHILLIPS —
MATTHEW L SULKALA —
ANDREW WESLEY WOMACK —

Contacted: Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); White House Office; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4710 (115th), S. 2453 (115th), S. 2312 (115th), S. 204 (115th), H.R. 878 (115th)

Copyright/Patent/Trademark CPT

Intellectual property and process patent issues. General IP issues. Patent litigation reform.

LobbyistCovered position, as disclosed
DAVID B BURT —
CATHERINE LYTTON PHILLIPS —

Contacted: SENATE; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); White House Office; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

H.R. 4710 - 340B Protecting Access for the Underserved and Safety-Net Entities Act. S. 2312 - The Helping Ensure Low-income Patients have Access to Care and Treatment Act S. 2453 - Ensuring the Value of the 340B Program Act of 2018 Part D Medicare Program (including Coverage Gap and other offsets in H.R.1892/P.L.115-123, Bipartisan Budget Act of 2018). Issues related to Medicare and Medicaid coverage and reimbursement Issues related to the 340B Drug Discount Program Issues related to RX drug pricing Medicare reimbursement for biosimilars MACRA treatment and reimbursement of Part B drugs Medicare payments for inpatient antimicrobials

LobbyistCovered position, as disclosed
DAVID B BURT —
ELISE MARIE CONNER —
CATHERINE LYTTON PHILLIPS —
MATTHEW L SULKALA —
ANDREW WESLEY WOMACK —

Contacted: Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2312 (115th), H.R. 4710 (115th), H.R. 1892 (115th), S. 2453 (115th)

Budget/Appropriations BUD

H.R.3358/S.1771, Departments of Labor, Health, and Human Services, and Education, and Related Agencies Appropriations Act, 2018 H.R.3268/S.1603, Agriculture, Rural Development, Food, and Drug Administration, and Related Agencies Appropriations Act, 2018 H.R.1370, Further Additional Continuing Appropriations Act, 2018 H.R.1892, Bipartisan Budget Act of 2018 H.R.1625, Consolidated Appropriations Act, 2018 Issues related to FDA and HHS program funding for the FY18 Labor, Health and Human Services, and Education and Related Agencies, and FY18 Agriculture, Rural Developments, Food, and Drug Administrations, and Related Agencies Appropriation bills Issues related to FDA and HHS program funding for the FY19 Labor, Health and Human Services, and Education and Related Agencies, and FY18 Agriculture, Rural Developments, Food, and Drug Administrations, and Related Agencies Appropriation bills

LobbyistCovered position, as disclosed
DAVID B BURT —
ELISE MARIE CONNER —
CATHERINE LYTTON PHILLIPS —
MATTHEW L SULKALA —
ANDREW WESLEY WOMACK —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); White House Office; SENATE; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Bills named: S. 1771 (115th), S. 1603 (115th), H.R. 1892 (115th), H.R. 3358 (115th), H.R. 1625 (115th), H.R. 3268 (115th), H.R. 1370 (115th)

Pharmacy PHA

Drug Pricing Issues Prescription Drug User Fee Act reauthorization. HR 4710, 340B Pause Act and other issues relating to the 340B Drug Discount Program

LobbyistCovered position, as disclosed
DAVID B BURT —
ELISE MARIE CONNER —
CATHERINE LYTTON PHILLIPS —
MATTHEW L SULKALA —
ANDREW WESLEY WOMACK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; Executive Office of the President (EOP); Office of Management & Budget (OMB)

Bills named: H.R. 4710 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.